This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Acute Myeloid Leukemia
and you are
between 18 and 100
years old
This is an advanced phase trial assessing
the effectiveness of the new treatment before being released on the market.
Show me locations

The purpose

The primary objective of the trial is to compare the two-year relapse-free survival (RFS) of patients with acute myeloid leukemia (AML), presumed to be at high risk for relapse due to the presence of leukemia stem cells (LSCs) in their bone marrow at first complete remission (CR1), who receive either standard cytarabine-based chemotherapy or allogeneic stem cell transplantation (SCT).

Provided treatments

  • Drug: Cytarabine consolidation
  • Drug: Allogeneic transplant

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01588951. The sponsor of the trial is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and it is looking for 10 volunteers for the current phase.
Official trial title:
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior